MXPA02007675A - Formulacion anticonceptiva masculina que comprende noretisterona. - Google Patents
Formulacion anticonceptiva masculina que comprende noretisterona.Info
- Publication number
- MXPA02007675A MXPA02007675A MXPA02007675A MXPA02007675A MXPA02007675A MX PA02007675 A MXPA02007675 A MX PA02007675A MX PA02007675 A MXPA02007675 A MX PA02007675A MX PA02007675 A MXPA02007675 A MX PA02007675A MX PA02007675 A MXPA02007675 A MX PA02007675A
- Authority
- MX
- Mexico
- Prior art keywords
- norethisterone
- testosterone
- male contraceptive
- males
- progestin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Una formulacion para prevenir la concepcion masculina que comprende una progestina que posee propiedades tanto androgenicas como estrogenicas es sorprendentemente eficaz para suprimir la espermatogenesis en varones. Se emplean la progestina Noretisterona (NET), particularmente sus derivados acetato de Noretisterona y enantato de Noretisterona en dosis suficientes como para inducir la oligozoospermia o la azoospermia en machos. Las formulaciones que comprenden ademas un androgeno, tal como un derivado de testosterona tal como un ester de testosterona, particularmente undecanoato de testosterona, son especialmente eficaces como formulaciones anticonceptivas masculinas.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50372900A | 2000-02-15 | 2000-02-15 | |
| EP00200493 | 2000-02-15 | ||
| PCT/IB2001/000188 WO2001060376A1 (en) | 2000-02-15 | 2001-02-15 | Male contraceptive formulation comprising norethisterone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02007675A true MXPA02007675A (es) | 2004-02-26 |
Family
ID=26071832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02007675A MXPA02007675A (es) | 2000-02-15 | 2001-02-15 | Formulacion anticonceptiva masculina que comprende noretisterona. |
Country Status (26)
| Country | Link |
|---|---|
| EP (2) | EP1666044B1 (es) |
| JP (1) | JP2003522795A (es) |
| KR (1) | KR20020086905A (es) |
| CN (1) | CN1423560A (es) |
| AT (2) | ATE355844T1 (es) |
| AU (1) | AU2001230447A1 (es) |
| BG (1) | BG107066A (es) |
| BR (1) | BR0108411A (es) |
| CA (1) | CA2398063A1 (es) |
| CY (1) | CY1106639T1 (es) |
| CZ (1) | CZ20022691A3 (es) |
| DE (2) | DE60127103T2 (es) |
| DK (1) | DK1267885T3 (es) |
| EE (1) | EE200200454A (es) |
| ES (1) | ES2282230T3 (es) |
| HK (1) | HK1049442B (es) |
| HU (1) | HUP0300128A3 (es) |
| IL (1) | IL151219A0 (es) |
| MX (1) | MXPA02007675A (es) |
| NO (1) | NO20023607L (es) |
| PL (1) | PL357185A1 (es) |
| PT (1) | PT1267885E (es) |
| RU (1) | RU2002124602A (es) |
| SI (1) | SI1267885T1 (es) |
| SK (1) | SK11602002A3 (es) |
| WO (1) | WO2001060376A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10234525A1 (de) * | 2002-07-25 | 2004-02-05 | Schering Ag | Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung |
| TW200404552A (en) * | 2002-05-30 | 2004-04-01 | Akzo Nobel Nv | Self administered contraception |
| PL373808A1 (en) | 2002-07-24 | 2005-09-19 | Schering Aktiengesellschaft | Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| CN1671394A (zh) * | 2002-07-25 | 2005-09-21 | 舍林股份公司 | 包含雄激素性11β－卤素甾体和孕激素的组合物以及基于该组合物的雄性避孕药 |
| CN101352443B (zh) * | 2007-07-23 | 2011-01-12 | 中国科学院动物研究所 | 哺乳动物雄性不育剂 |
| US10912762B2 (en) | 2018-03-23 | 2021-02-09 | Laboratoires Major | Non-hormonal compositions and methods for male contraception |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2714420A1 (de) * | 1976-06-01 | 1977-12-08 | Int Pregnancy Advisory Service | Antikonzeptionsmittel zur verabreichung an mann und frau in einer gemeinsamen verabreichungspackung |
| US4210644A (en) | 1978-02-23 | 1980-07-01 | The Johns Hopkins University | Male contraception |
| US5035891A (en) | 1987-10-05 | 1991-07-30 | Syntex (U.S.A.) Inc. | Controlled release subcutaneous implant |
| CN1102095A (zh) * | 1993-10-30 | 1995-05-03 | 浙江医科大学 | 长效雄激素类制剂——十一酸睾丸注射液 |
| DE19650352A1 (de) * | 1996-12-04 | 1998-07-30 | Jenapharm Gmbh | Oral wirksames Kombinationspräparat zur Kontrazeption für den Mann |
-
2001
- 2001-02-15 JP JP2001559472A patent/JP2003522795A/ja active Pending
- 2001-02-15 EP EP06075322A patent/EP1666044B1/en not_active Expired - Lifetime
- 2001-02-15 MX MXPA02007675A patent/MXPA02007675A/es unknown
- 2001-02-15 EP EP01902590A patent/EP1267885B8/en not_active Expired - Lifetime
- 2001-02-15 DE DE60127103T patent/DE60127103T2/de not_active Expired - Lifetime
- 2001-02-15 IL IL15121901A patent/IL151219A0/xx unknown
- 2001-02-15 AT AT01902590T patent/ATE355844T1/de active
- 2001-02-15 AU AU2001230447A patent/AU2001230447A1/en not_active Abandoned
- 2001-02-15 RU RU2002124602/15A patent/RU2002124602A/ru not_active Application Discontinuation
- 2001-02-15 WO PCT/IB2001/000188 patent/WO2001060376A1/en active IP Right Grant
- 2001-02-15 DK DK01902590T patent/DK1267885T3/da active
- 2001-02-15 SI SI200130726T patent/SI1267885T1/sl unknown
- 2001-02-15 DE DE60142647T patent/DE60142647D1/de not_active Expired - Lifetime
- 2001-02-15 PT PT01902590T patent/PT1267885E/pt unknown
- 2001-02-15 AT AT06075322T patent/ATE474580T1/de not_active IP Right Cessation
- 2001-02-15 BR BR0108411-9A patent/BR0108411A/pt not_active IP Right Cessation
- 2001-02-15 PL PL01357185A patent/PL357185A1/xx not_active Application Discontinuation
- 2001-02-15 CN CN01808041A patent/CN1423560A/zh active Pending
- 2001-02-15 KR KR1020027010715A patent/KR20020086905A/ko not_active Application Discontinuation
- 2001-02-15 CA CA002398063A patent/CA2398063A1/en not_active Abandoned
- 2001-02-15 HU HU0300128A patent/HUP0300128A3/hu unknown
- 2001-02-15 SK SK1160-2002A patent/SK11602002A3/sk unknown
- 2001-02-15 EE EEP200200454A patent/EE200200454A/xx unknown
- 2001-02-15 CZ CZ20022691A patent/CZ20022691A3/cs unknown
- 2001-02-15 ES ES01902590T patent/ES2282230T3/es not_active Expired - Lifetime
-
2002
- 2002-07-30 NO NO20023607A patent/NO20023607L/no not_active Application Discontinuation
- 2002-09-05 BG BG107066A patent/BG107066A/xx unknown
-
2003
- 2003-03-04 HK HK03101578.5A patent/HK1049442B/zh not_active IP Right Cessation
-
2007
- 2007-06-05 CY CY20071100743T patent/CY1106639T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106639T1 (el) | Τυποποιηση αντισυλληπτικου για ανδρες που περιλαμβανει νορεθιστερονη | |
| NO20032805D0 (no) | Preparater av östrogensyklodekstrinkomplekser | |
| GEP20053586B (en) | Selective Androgen Receptor Modulators and Pharmaceutical Compositions Containing the Same | |
| WO2001003687A3 (en) | Method and compositions for inhibiting biosynthesis or bioactivity of endogenous steroid sex hormones in humans | |
| RU99118582A (ru) | Композиция для чрескожного введения стероидных лекарственных средств | |
| AR073972A2 (es) | Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas | |
| HUP0200173A2 (en) | Combined use of estrogen and progestogen, norethindrone acetate and ethinyl estradiol for preparing pharmaceutical compositions for preventing and treating skin aging and acne | |
| DE59805902D1 (de) | Nichtestrogene derivate des estradiols mit antioxidativer aktivität | |
| WO2001040255A3 (en) | 14,15-beta-methylene substituted androgens | |
| AU1967300A (en) | Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 | |
| AR027526A1 (es) | Formulacion anticonceptiva masculina que comprende noretisterona | |
| JP2005532336A (ja) | 新規なエトノゲストレルエステルの使用 | |
| JP2003522795A5 (es) | ||
| HK1060135A1 (en) | 4-Halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds | |
| PE20020709A1 (es) | Composiciones de complejos de estrogeno-ciclodextrina | |
| MX2010004975A (es) | Uso de un gestageno en combinacion con un estrogeno y uno o varios excipientes/portadores farmaceuticamente aceptables para la anticoncepcion oral sin lactosa. |